Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2018 | ||||||||||||||||||||||||||||||||
| By: Nasdaq / GlobeNewswire - 13 Feb 2018 | Back to overview list |
|||||||||||||||||||||||||||||||
Bagsværd, Denmark, 13 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons. Further information
Company announcement No 15 / 2018 Attachments:http://www.globenewswire.com/NewsRoom/AttachmentNg/4621310f-644c-4737-941e-64027cfa1c82 |
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
 | Back to overview list | |||||||||||||||||||||||||||||||